Febs Journal

OCT 13, 2026 · JOURNAL ARTICLE

A guide to studying tumour‐T‐cell interactions using in vitro coculture assays

Febs Journal

T cells are central mediators of antitumour immunity and are the cellular basis of many successful cancer immunotherapies, including immune checkpoint blockade, T‐cell receptor (TC

OCT 6, 2026 · JOURNAL ARTICLE

Combining TAG ‐ 72CAR with anti‐ MUC16CAR improves the potency of ovarian cancer treatment

Febs Journal

Ovarian cancer (OC) is typically associated with poor prognosis and high mortality. Chimeric antigen receptor (CAR) T‐cell therapy offers a promising strategy, yet its application

AUG 12, 2026 · JOURNAL ARTICLE

Modalities to identify clinically actionable neoantigens

Febs Journal

A narrative review summarizing neoantigen identification strategies and discussing challenges; raises questions about mechanistic pathways rather than reporting empirical results with effect sizes.